Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03546010
Other study ID # 38RC14.100
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 5, 2014
Est. completion date December 31, 2018

Study information

Verified date June 2018
Source University Hospital, Grenoble
Contact Annie Laurent, MD
Phone 04 76 76 54 19
Email AnnieLaurent@chu-grenoble.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to analyse thanks to eye tracking experiments ocular movement classical parameters in children with attention deficit hyperactivity (ADH) and to compare them to results obtained in healthy children and to results obtained with neuropsychological tests commonly used in standard health care.

We should then be able to compare eye tracking with neuropsychological parameters.

The final objective is to give to health professional a tool for ADH investigation with which they should be able to do a simple and effective follow up of children with ADH.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date December 31, 2018
Est. primary completion date December 31, 2018
Accepts healthy volunteers No
Gender All
Age group 8 Years to 12 Years
Eligibility Inclusion Criteria:

- Children between 8 and 12 years old

- Boys and girls

- DSM-IV-TR diagnostic criteria for ADH

- Children with methylprednisone treatment

- Social security affiliation

- signed informed consent

Exclusion Criteria:

- specialised scholarship

- refusal from children or parents

- too law results in WISC test (pre-inclusion test)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Neuropsychological tests
WISC test, BRIEF test, NEPSY-2 test, TAP2.3 test, Teach test
Oculometric tests
When the subject see a peripheric target, he should take a look not at the target but in the controlateral half-field, at a mirror position. This is called an anti-saccade task.

Locations

Country Name City State
France Grenoble Alps Hospital Grenoble

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Grenoble

Country where clinical trial is conducted

France, 

References & Publications (1)

Malsert J, Guyader N, Chauvin A, Polosan M, Szekely D, Bougerol T, Marendaz C. Saccadic performance and cortical excitability as trait-markers and state-markers in rapid cycling bipolar disorder: a two-case follow-up study. Front Psychiatry. 2013 Jan 4;3:112. doi: 10.3389/fpsyt.2012.00112. eCollection 2012. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Correlation between oculometric and neuropsychological tests in ADH evaluation Differentiation between simple oculomotor disorder and attentional-visual disorder Day 1
See also
  Status Clinical Trial Phase
Completed NCT03945175 - Study of the Duration and Efficacy of MYDAYIS on Adult ADHD Symptoms and Executive Function Throughout the Day Into the Early Evening Phase 3
Completed NCT00205699 - Metabolic Effects of Antipsychotics in Children Phase 4